Home Nucleus Medical Devices U.S. Hereditary Cancer Testing Market to 2032

U.S. Hereditary Cancer Testing Market to 2032

Overview

The U.S. Hereditary Cancer Testing Market is expected to reach a 6.66 USD Billion by 2032 and is projected to grow at a CAGR of 21.60% from 2025 to 2032.

Revenue, 2024 (USD Billion)
2.41
Forecast, 2032 (USD Billion)
6.66
CAGR, 2024 - 2032
21.60%
Report Coverage
U.S.

U.S. Hereditary Cancer Testing Market 2018-2032 USD Billion

U.S. Hereditary Cancer Testing Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 2.41 USD Billion
  • Projected Market Size (2032): 6.66 USD Billion
  • CAGR (2025-2032): 21.60%

Key Findings of U.S. Hereditary Cancer Testing Market

  • The U.S. Hereditary Cancer Testing Market was valued at 2.41 USD Billion in 2024.
  • The U.S. Hereditary Cancer Testing Market is likely to grow at a CAGR of 21.60% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 1.61 USD Billion
  • The fastest growing segment Hospitals in End Users Segment grew Fastest with a CAGR of 22.68% during the forecast period from 2024 to 2032.

U.S. Hereditary Cancer Testing Market Scope

U.S. Hereditary Cancer Testing Market Segmentation & Scope
Diagnosis
  • Lab Tests
  • Imagining
  • Biopsy
Test
  • Single Site Genetic Test
  • Multi Panel Test
Disease
  • Multiple Endocrine Neoplasias (MEN) Syndrome
  • Von Hippel-Lindau Disease
  • Li-Fraumeni Syndrome
  • Familial Adenomatous Polyposis (FAP)
  • Hereditary Leukemia and Hematologic Malignancies Syndrome
  • Lynch Syndrome
  • Cowden Syndrome
  • Hereditary Breast & Ovarian Cancer Syndrome
Technology
  • Microarray
  • Sequencing
  • Polymerase Chain Reaction (PCR)
End Users
  • Others
  • Laboratories
  • Radiology Centres
  • Diagnostics Centers
  • Clinics
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender

U.S. Hereditary Cancer Testing Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 2.41 USD Billion
Market Value in 2032 6.66 USD Billion
CAGR (2025-2032) 21.60%
Historic Data 2016-2023
Market Segments Covered Diagnosis,Test,Disease,Technology,End Users,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 2.41 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 2,413.39 USD Million in 2024.

Segments and Scope

  • U.S. Hereditary Cancer Testing Market to 2032, By Diagnosis
    • Biopsy is the largest segment in U.S. Hereditary Cancer Testing Market to 2032 with a revenue of 1.00 USD Billion in the year 2024.
    • Biopsy is the Fastest growing segment in U.S. Hereditary Cancer Testing Market to 2032 with a Growth rate of 22.00 % in forecast period 2025-2032.
  • U.S. Hereditary Cancer Testing Market to 2032, By Test
    • Multi Panel Test is the largest segment in U.S. Hereditary Cancer Testing Market to 2032 with a revenue of 1.57 USD Billion in the year 2024.
    • Multi Panel Test is the Fastest growing segment in U.S. Hereditary Cancer Testing Market to 2032 with a Growth rate of 22.02 % in forecast period 2025-2032.
  • U.S. Hereditary Cancer Testing Market to 2032, By Disease
    • Hereditary Breast & Ovarian Cancer Syndrome is the largest segment in U.S. Hereditary Cancer Testing Market to 2032 with a revenue of 1.31 USD Billion in the year 2024.
    • Hereditary Breast & Ovarian Cancer Syndrome is the Fastest growing segment in U.S. Hereditary Cancer Testing Market to 2032 with a Growth rate of 22.37 % in forecast period 2025-2032.
  • U.S. Hereditary Cancer Testing Market to 2032, By Technology
    • Polymerase Chain Reaction (PCR) is the largest segment in U.S. Hereditary Cancer Testing Market to 2032 with a revenue of 1.53 USD Billion in the year 2024.
    • Polymerase Chain Reaction (PCR) is the Fastest growing segment in U.S. Hereditary Cancer Testing Market to 2032 with a Growth rate of 22.11 % in forecast period 2025-2032.
  • U.S. Hereditary Cancer Testing Market to 2032, By End Users
    • Hospitals is the largest segment in U.S. Hereditary Cancer Testing Market to 2032 with a revenue of 825.43 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in U.S. Hereditary Cancer Testing Market to 2032 with a Growth rate of 22.68 % in forecast period 2025-2032.
  • U.S. Hereditary Cancer Testing Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Hereditary Cancer Testing Market to 2032 with a revenue of 1.61 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Hereditary Cancer Testing Market to 2032 with a Growth rate of 21.79 % in forecast period 2025-2032.

U.S. Hereditary Cancer Testing Market Company Share Analysis

 
Company Name Company Share Analysis
PerkinElmer Inc.
illumina, inc.
Abbott
Eurofins Scientific
LifeLabs Genetics
U.S. Hereditary Cancer Testing Market Company Share Analysis

U.S. Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Hereditary Cancer Testing Market Company Profiling

U.S. Hereditary Cancer Testing Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.S. Hereditary Cancer Testing Market is segmented based on Segmentation Diagnosis,Test,Disease,Technology,End Users,Distribution Channel.
U.S. Hereditary Cancer Testing Market was valued at USD 2.41(Revenue in USD Billion) in 2020.
U.S. Hereditary Cancer Testing Market is projected to grow at a CAGR of 21.60% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the U.S. Hereditary Cancer Testing Market, holding a largest market share of 1.61 USD Billion in 2024

U.S. Hereditary Cancer Testing Market Scope

U.S. Hereditary Cancer Testing Market Segmentation & Scope
Diagnosis
  • Lab Tests
  • Imagining
  • Biopsy
Test
  • Single Site Genetic Test
  • Multi Panel Test
Disease
  • Multiple Endocrine Neoplasias (MEN) Syndrome
  • Von Hippel-Lindau Disease
  • Li-Fraumeni Syndrome
  • Familial Adenomatous Polyposis (FAP)
  • Hereditary Leukemia and Hematologic Malignancies Syndrome
  • Lynch Syndrome
  • Cowden Syndrome
  • Hereditary Breast & Ovarian Cancer Syndrome
Technology
  • Microarray
  • Sequencing
  • Polymerase Chain Reaction (PCR)
End Users
  • Others
  • Laboratories
  • Radiology Centres
  • Diagnostics Centers
  • Clinics
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Frequently Asked Questions
The U.S. Hereditary Cancer Testing Market is segmented based on Segmentation Diagnosis,Test,Disease,Technology,End Users,Distribution Channel.
U.S. Hereditary Cancer Testing Market was valued at USD 2.41(Revenue in USD Billion) in 2020.
U.S. Hereditary Cancer Testing Market is projected to grow at a CAGR of 21.60% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Hereditary Cancer Testing Market for final year is USD 6.66 (USD Billion).

U.S. Hereditary Cancer Testing Market Company Profiling

U.S. Hereditary Cancer Testing Market Company Profiling
Frequently Asked Questions
The U.S. Hereditary Cancer Testing Market is segmented based on Segmentation Diagnosis,Test,Disease,Technology,End Users,Distribution Channel.
U.S. Hereditary Cancer Testing Market was valued at USD 2.41(Revenue in USD Billion) in 2020.
U.S. Hereditary Cancer Testing Market is projected to grow at a CAGR of 21.60% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Hereditary Cancer Testing Market for final year is USD 6.66 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES